AnaptysBio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	232.39	234.6	91.28	17.16	10.29	63.18
Revenue Growth (YoY)	107.73%	157.01%	432.03%	66.78%	-83.72%	-15.77%
Gross Profit	232.39	234.6	91.28	17.16	10.29	63.18
Selling, General & Admin	62.81	50.74	42.39	41.95	36.64	21.49
Research & Development	128.78	135.97	163.84	132.28	88.8	98.5
Other Operating Expenses	-	-	-	7.34	-	-
Total Operating Expenses	191.59	186.71	206.23	181.57	125.44	119.99
Operating Income	40.8	47.9	-114.95	-164.41	-115.15	-56.81
Interest Income	11.74	13.5	19.79	18.87	7.55	0.43
Interest Expense	-82.69	-79.89	-50.09	-18.08	-21.11	-1.45
Other Non-Operating Income (Expense)	-63.9	-55.53	-30.27	0.79	-13.53	-0.95
Total Non-Operating Income (Expense)	-134.85	-121.93	-60.56	1.58	-27.09	-1.96
Pretax Income	-26.63	-13.07	-145.23	-163.62	-128.7	-57.8
Provision for Income Taxes	-0.16	-0.16	-0	0	-0.02	-
Net Income	-26.79	-13.23	-145.23	-163.62	-128.72	-57.8
Net Income to Common	-26.79	-13.23	-145.23	-163.62	-128.72	-57.8
Shares Outstanding (Basic)	28	29	28	27	28	27
Shares Outstanding (Diluted)	29	29	28	27	28	27
Shares Change (YoY)	0.44%	1.32%	5.42%	-4.41%	2.68%	0.47%
EPS (Basic)	-0.85	-0.46	-5.12	-6.08	-4.57	-2.11
EPS (Diluted)	-1.08	-0.46	-5.12	-6.08	-4.57	-2.11
Shares Outstanding	29.03	28.02	30.47	26.6	28.51	27.65
Free Cash Flow	4.41	19.61	-135.7	-121.61	-73.95	-47.29
Free Cash Flow Growth	-77.52%	-	-	-	-	-
Free Cash Flow Per Share	0.15	0.68	-4.78	-4.52	-2.63	-1.72
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	17.56%	20.42%	-125.93%	-958.27%	-1119.41%	-89.93%
Profit Margin	-11.53%	-5.64%	-159.11%	-953.66%	-1251.33%	-91.49%
FCF Margin	1.90%	8.36%	-148.66%	-708.79%	-718.88%	-74.85%
EBITDA	41.34	48.46	-114.34	-163.76	-114.48	-56.2
EBITDA Margin	17.79%	20.65%	-125.27%	-954.47%	-1112.85%	-88.95%
EBIT	40.8	47.9	-114.95	-164.41	-115.15	-56.81
EBIT Margin	17.56%	20.42%	-125.93%	-958.27%	-1119.41%	-89.93%
Effective Tax Rate	0.60%	1.25%	0.00%	-0.00%	0.02%	0.00%

SEC Filings: 10-K · 10-Q